Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$251.58
+1.58%
Mkt Cap $34.52B
Analyst Ratings
Buy
23
Hold
6
Sell
0
Price Target (69 analysts)
$454.27
Range $370.00 – $530.00
Implied Upside
+80.6%
Consensus $454.27 vs current $251.58